Literature DB >> 8059335

Imaging endogenous dopamine competition with [11C]raclopride in the human brain.

N D Volkow1, G J Wang, J S Fowler, J Logan, D Schlyer, R Hitzemann, J Lieberman, B Angrist, N Pappas, R MacGregor.   

Abstract

This study images dopamine release in response to a neurochemically specific challenge with the psychostimulant drug methylphenidate. Changes in synaptic dopamine induced by methylphenidate were evaluated with positron emission tomography and [11C]raclopride, a D2 receptor radioligand that is sensitive to endogenous dopamine. Methylphenidate significantly decreased striatal [11C]raclopride binding. The decrease was variable and was negatively correlated with age. Mood and anxiety at baseline, were also correlated with methylphenidate-induced DA changes. This strategy provides a tool to investigate the responsiveness of the dopamine system in the normal and diseased human brain and to investigate the neurochemical correlates of behavior.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8059335     DOI: 10.1002/syn.890160402

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  87 in total

Review 1.  [Neuroimaging in substance abuse disorders].

Authors:  A de Mendelssohn; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

2.  Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach.

Authors:  Sjoerd J Finnema; Andrea Varrone; Tzung-Jeng Hwang; Christer Halldin; Lars Farde
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-14       Impact factor: 6.200

3.  Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.

Authors:  Nora D Volkow; Gene-Jack Wang; Dardo Tomasi; Scott H Kollins; Tim L Wigal; Jeffrey H Newcorn; Frank W Telang; Joanna S Fowler; Jean Logan; Christopher T Wong; James M Swanson
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

4.  Smoking produces rapid rise of [11C]nicotine in human brain.

Authors:  Marc S Berridge; Scott M Apana; Kenichi K Nagano; Catherine E Berridge; Gregory P Leisure; Mark V Boswell
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

5.  Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Authors:  Kristina Simonyan; Brian D Berman; Peter Herscovitch; Mark Hallett
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 6.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

7.  Are Internet use and video-game-playing addictive behaviors? Biological, clinical and public health implications for youths and adults.

Authors:  Yvonne H C Yau; Michael J Crowley; Linda C Mayes; Marc N Potenza
Journal:  Minerva Psichiatr       Date:  2012-09-01

8.  Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.

Authors:  Nora D Volkow; Joanna S Fowler; Jean Logan; David Alexoff; Wei Zhu; Frank Telang; Gene-Jack Wang; Millard Jayne; Jacob M Hooker; Christopher Wong; Barbara Hubbard; Pauline Carter; Donald Warner; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Karen Apelskog-Torres
Journal:  JAMA       Date:  2009-03-18       Impact factor: 56.272

9.  Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; Zoe Allen-Martinez; David Scheibal; Anna L Abrams; Matthew R Costello; Judah Farahi; Sanjaya Saxena; John Monterosso; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2008-06-18       Impact factor: 7.853

Review 10.  Emerging association between addictive gaming and attention-deficit/hyperactivity disorder.

Authors:  Aviv Weinstein; Abraham Weizman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.